A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study

Table 2

Baseline characteristics of NAFLD and non-NAFLD patients in the training cohort.

Characteristics	Non-NAFLD	NAFLD	value
No. of participants	3,687	918
Age (years)			<0.001
ALP (U/L)			<0.001
Lg (GGT) (U/L)			<0.001
Lg (ALT) (U/L)			<0.001
AST (U/L)			<0.001
TP (U/L)			0.075
ALB (U/L)			0.024
GLB (U/L)			0.704
Lg (TB) (mmol/L)			0.142
Lg (DBIL) (mmol/L)			<0.001
BUN (mmol/L)			0.502
Cr (μmol/L)			<0.001
UA (μmol/L)			<0.001
FPG (mmol/L)			<0.001
TC (mmol/L)			<0.001
Lg (TG) (mmol/L)			<0.001
HDL-c (mmol/L)			<0.001
LDL-c (mmol/L)			<0.001
BMI (kg/m2)			<0.001
SBP (mmHg)			<0.001
DBP (mmHg)			<0.001
Follow-up (days)			<0.001
Gender (, %)			0.227
Female	1644 (44.59%)	389 (42.37%)
Male	2043 (55.41%)	529 (57.63%)

Data are (%) or NAFLD: nonalcoholic fatty liver disease; ALP: alkaline phosphatase; GGT: γ-glutamyl transpeptidase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TP: total protein; ALB: albumin; GLB: globulin; TB: total bilirubin; DBIL: direct bilirubin; BUN: blood urea nitrogen; Cr: creatinine; UA: uric acid; FPG: fasting plasma glucose; TC: total cholesterol; TG: triglyceride; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure.